Peranpanel and Levetiracetam vs Levetiracetam doze up Phase 2 study for brain tumor related epilepsy (Phase 2, PPAP study)
Phase 2
- Conditions
- brain tumor related epilepsy, high grade glioma
- Registration Number
- JPRN-UMIN000029585
- Lead Sponsor
- Department of Neurosurgery, Hirosaki University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Simultaneous or metachronous (within the past 5 years) double cancers, with the exception of intramucosal tumor curable with local therapy 2) Infection with systemic therapy indicated 3) fever over 38 degrees Celsius 4) Active infectious meningitis 5) Women during pregnancy, possible pregnancy or breast-feeding 6) Psychosis 7) Uncontrollable diabetes mellitus or administration of insulin 8) Unstable angina within 3 weeks, or with a history of myocardial infarction within 6 months 9) Interstitial pneumonia, or fibroid lung 10) Patients who can't receive gadolinium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method